Rutin could lighten M5‐induced inflammation and abnormal differentiation in HaCaT cells by mediating the JAK2/STAT3 signaling, which offers evidence to bolster the potential of Rutin as a drug for managing psoriasis. The gene discussed is STAT3; the disease is psoriasis.